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Background: The purpose of this study was to analyze the hospital, clinical, and patient factors associated
with inpatient readmission after total hip arthroplasty (THA) in the Medicare population and to
understand the primary reasons for readmission.
Methods: The Medicare 100% national hospital claims database was used to identify 442,333 older
patients (65þ) with a primary THA in 3730 hospitals between 2010 and 2013. A multilevel logistic
regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and
90-day readmission, incorporating hospital, clinical, and patient factors.
Results: At 30 days, 5.8% (median) of the patients were readmitted, whereas at 90 days, 10.5% (median)
were readmitted. Geographic census region, hospital procedure volume, and nonproﬁt ownership were
the only signiﬁcant hospital factors among those we studied. Overall, clinical factors explained more of
the variation in readmission rates than general hospital factors. Use of a perioperative transfusion was
associated with 14% greater risk, patients discharged to home had 28% lower risk, and surgeon volume
and length of stay were also signiﬁcant risk factors. The top 5 most frequently reported primary reasons
for 30-day readmission in THA were procedure related: dislocation (5.9%), deep infection (5.1%), wound
infection (4.8%), periprosthetic fracture (4.4%), or hematoma (3.4%).
Conclusion: These ﬁndings support further optimization of the delivery of caredboth intraoperative and
postoperativedto reduce the broad variation in hospital readmissions.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Galvanized by the Affordable Care and Patient Protection Act of
2010, health care reform in the United States is resulting in disrup-
tive changes to the reimbursement of orthopedic surgery [1-3].Stryker Orthopaedics.
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Inc. This is an open access article uThe traditional fee-for-service paradigm is changing into an episode
of care model in which afﬁliated health care providers coordinate
services into a single payment bundle, covering up to 90 days after
discharge from the hospital [4]. In theory, patient-centered coordi-
nation of care is thought to provide incentives for stakeholders to
provide the optimal care at a reduced, sustainable cost. In practice,
the success of a bundled care model, from both patient and societal
perspectives, is predicated on assuring that quality of care is not
sacriﬁced to simply achieve lower costs and maximize proﬁt
for provider stakeholder(s) in control of a patient’s payment
bundle [1-3].
To achieve these quality goals, the Centers for Medicare and
Medicaid Services (CMS) has recently introduced a series of hos-
pital quality measures or benchmarks speciﬁcally for total joint
arthroplasty [5]. One such hospital quality benchmark, known asnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Centers for Medicare and Medicaid Services Limited Data Set Inpatient Data 2010-2013: Patients Undergoing THA and Rehospitalized (All Cause) in 30 or 90 Days and
Demographic Proﬁle and Hospital Characteristics of Primary and Readmitted Patients.
Effect Level THA Readmit 30 Days Readmit 90 Days THA (%) Readmit 30 Days (%) Readmit 90 Days (%)
Total 442,333 26,076 45,242 100.0 100.0 100.0
Age 65-69 123,690 5195 9046 28.0 19.9 20.0
70-74 116,075 5797 9978 26.2 22.2 22.1
75-79 96,250 5908 10,243 21.8 22.7 22.6
80-84 68,244 5272 9122 15.4 20.2 20.2
85þ 38,074 3904 6853 8.6 15.0 15.1
CCI 00 243,948 10,752 18,093 55.2 41.2 40.0
1-2 156,320 10,500 18,310 35.3 40.3 40.5
3-4 32,600 3341 6050 7.4 12.8 13.4
5þ 9465 1483 2789 2.1 5.7 6.2
Discharge type Home 77,158 2842 4716 17.4 10.9 10.4
Home with HHS 146,499 5671 9692 33.1 21.7 21.4
Other facility 5452 1384 1687 1.2 5.3 3.7
Rehab facility 51,212 4251 7688 11.6 16.3 17.0
SNF 162,012 11,928 21,459 36.6 45.7 47.4
Hospital annual TJA volume 001-149 87,287 6102 10,330 19.7 23.4 22.8
150-299 125,084 7546 13,122 28.3 28.9 29.0
300-449 83,086 4651 8125 18.8 17.8 18.0
450-599 53,996 2967 5251 12.2 11.4 11.6
600þ 92,880 4810 8414 21.0 18.4 18.6
Hospital beds 001-149 94,096 5570 9261 21.3 21.4 20.5
150-299 123,386 7288 12,695 27.9 27.9 28.1
300-499 114,551 6774 11,882 25.9 26.0 26.3
500þ 110,300 6444 11,404 24.9 24.7 25.2
Hospital ownership Nonproﬁt 68,775 4382 7444 15.5 16.8 16.5
Private 327,524 19,013 33,138 74.0 72.9 73.2
Public 46,033 2680 4659 10.4 10.3 10.3
Unknown 1 1 1 0.0 0.0 0.0
Hospital setting Rural 53,996 3369 5789 12.2 12.9 12.8
Urban 388,337 22,707 39,453 87.8 87.1 87.2
Hospital stay 1-2 87,078 3303 5344 19.7 12.7 11.8
3-4 299,757 16,008 28,029 67.8 61.4 62.0
5þ 55,498 6765 11,869 12.5 25.9 26.2
Hospital teaching No 302,226 17,792 30,803 68.3 68.2 68.1
Yes 140,107 8284 14,439 31.7 31.8 31.9
Race Black 19,890 1311 2282 4.5 5.0 5.0
Other/unknown 8807 494 858 2.0 1.9 1.9
White 413,636 24,271 42,102 93.5 93.1 93.1
Resident region Midwest 119,193 7094 12,196 26.9 27.2 27.0
Northeast 82,893 5078 8645 18.7 19.5 19.1
South 156,097 9802 17,209 35.3 37.6 38.0
West 84,150 4102 7192 19.0 15.7 15.9
Gender Female 276,478 15,893 28,170 62.5 60.9 62.3
Male 165,855 10,183 17,072 37.5 39.1 37.7
THA, total hip arthroplasty; TJA, total joint arthroplasty; CCI, Charlson Comorbidity Index; HHS, home health service; SNF, skilled nursing facility.
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each hospital relative to a national average and reported publicly on
the Internet (https://www.medicare.gov/hospitalcompare/search.
html). Thus, prospective patients can consider this information
when deciding where to have their surgery performed. Further-
more, hospitals that are found by CMS to have “excess” 30-day
readmission rates can be ﬁnancially penalized by retrospectively
having up to 3% of their payments withheld or “clawed back” [6].
Although 30-day readmission rates are considered to be a hospital
quality measure, 90-day readmissions are equally relevant as the
maximum window for an episode of care, during which the
stakeholders in the payment bundle are liable for all of the costs
associated with patient treatment, regardless of whether or not the
reason for readmission is related to the index orthopedic surgery
[1-3]. Thus, both hospital and bundled care providers currently
have both concerns and explicit incentives to minimize 30- and
90-day readmissions risks.
In light of these developments, recent research has been focused
on the factors associated with hospital readmissions after THA
[6-12]. Previous studies have examined patient factors and clinical
factors associated with readmission in a single institution [6-12].Comparatively few studies have examined THA readmission across
multiple institutions [10,11,13,14], and little is known about the role
of hospital factors and how they inﬂuence the overall risk of
readmission after primary THA.
To add to the knowledge base on 30- and 90-day readmissions
after THA, we studied the hospital as the unit of analysis and asked
the following research questions for the Medicare population of
primary THA patients: (1) Which hospital factors inﬂuence 30- and
90-day readmissions after primary THA? (2) Which clinical factors
inﬂuence 30- and 90-day readmissions? (3) What are the principal
reasons for 30- and 90-day hospital readmissions and are they
procedure related?
Materials and Methods
This study is based on analysis of the 100% Medicare inpatient
limited data set (LDS), from which we identiﬁed 442,333 patients
(65þ years old) who received a primary THA between 2010 and
2013 (Table 1). The LDS ﬁles contain conventional fee-for-service
claims submitted to CMS for payment, and in recent years, 12-13
million claims for hospital services are processed annually by CMS.
Fig. 1. Geographic variation in (A) 30- and (B) 90-day all-cause hospital readmission after total hip arthroplasty by state and county in the 100% Medicare data set (2010-2013).
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Fig. 2. Relative signiﬁcanceof patient, hospital, and clinical factors for 30-day readmissionafter total hip arthroplasty in the100%Medicaredata set (2010-2013), basedon the F statistics
of ﬁxed-effect model. TJA, total joint arthroplasty; CCI, Charlson Comorbidity Index; LOS, length of stay; CMS, Centers for Medicare and Medicaid Services; LDS, limited data set.
Fig. 3. Relative signiﬁcance of patient, hospital, and clinical factors for 90-day readmission after total hip arthroplasty in the 100% Medicare data set (2010-2013), based on the F
statistics of ﬁxed-effect model.
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S.M. Kurtz et al. / The Journal of Arthroplasty 31 (2016) 2130e21382134In 2010-2013, approximately 20%-25% of Medicare beneﬁciaries
received their care through a Medicare-approved HMO under the
Medicare Advantage program. Records of hospital care through a
Medicare Health Maintenance Organization (HMO) are not sub-
mitted to CMS and not part of the LDS data ﬁle. The LDS data
capture the vast majority of patients in the Medicare program and
are broadly representatively of the hospital experience of patients
who receive THA in the US. A unique, encrypted beneﬁciary ID is
used to identify an initial THA admission and any subsequent
readmission across multiple years in the data set for each beneﬁ-
ciary in the LDS data. Hospitals are uniquely identiﬁed by a non-
encrypted provider ID in the data set; helping incorporation of
hospital characteristics in the present study. Because the Medicare
is a nationwide program, patients need not return to the same
hospital as their initial THA to be tracked and identiﬁed, an
advantage over many institution-based studies where out-of-
system re-admission cannot be tracked.
Primary THA procedures were identiﬁed using International
Classiﬁcation of Diseases, 9th Revision, Clinical Modiﬁcation (ICD-
9-CM) code 81.51. During the study period, claims data were sub-
mitted by 3730 hospitals toMedicare for THA. Hospital and surgeon
volume estimates were limited to theMedicare population and, as a
proxy for experience, were assumed to correlate with the overall
volume of the hospital or of the surgeon. Patients aged <65 years,
enrolled in an HMO, or residing outside the 50 US states were
excluded in this analysis. To evaluate preoperative factors,
including comorbidities, hospital volume, and surgeon volume, we
used the patient claims history for 1 year before their index THA as
a “look-back period.” For those patients who received their primary
THA in 2010, we used the 100% inpatient data from 2009 for the
look-back period. Patients were tracked longitudinally for 30 and
90 days after their primary THA procedure. Patients who died
within the 30-day or 90-day period without encountering read-
mission were excluded because they did not have the opportunity
to be readmitted. We determined readmission as the appearance of
new hospital claims record for the patient within 30 or 90 days of
the patient's discharge date. Patients who returned to the hospital
only for rehabilitation service (ICD-9-CM: V57.x) and not associated
with complications or other medical issues were not included.
We used a multilevel logistic regression analysis with a clus-
tered data structure, in which the hospital was considered the
“cluster” or top-level unit of analysis. The model incorporated a
“multilevel” approach, including individual level factors (eg, age,
gender, comorbidity) and group level (hospital) factors (eg, bed
size, type of hospital) in the same model. By using a “clustered”
approach, patients were grouped or clustered by the hospital in
which they were treated. Thus, we accounted for those who were
treated in the same hospital and shared a common institutional-
level risk of readmission, above and beyond their personal risk
factors. These clustered recordswere captured as a hospital random
effect (ie, a random intercept) for each hospital, and the additional
risk factors were added to the overall hospital level.
We studied the hospital geographic location (rural or urban),
bed size, type of hospital (eg, proﬁt vs nonproﬁt, teaching vs
nonteaching) as hospital factors, and length of stay (LOS), discharge
status (home vs skilled nursing facility [SNF]), and use of trans-
fusion as clinical factors. We included the following individual
patient factors: age, gender, race, census region, Medicare buy-in
status (a proxy for socioeconomic status), Charlson Comorbidity
Score, and the presence of one or more speciﬁc comorbidities
including anemia, depression, diabetes, drug/alcohol abuse, heart
failure, lymphoma, obesity, pulmonary condition, renal disease,
and/or the diagnosis of a secondary tumor.
Statistical analyses were performed using the SAS statistical
software, release 9.4 (Cary, NC). The results were consideredsigniﬁcant for statistical tests with P < .05. For many factors with
the same signiﬁcant P value (eg, <.0001), we examined, addition-
ally, the type III tests of ﬁxed effect as measured by the F statistics,
as an indicator for the relative importance of these hospital and
patient factors on 30-day or 90-day readmissions. The type III F
statistics of a particular factor measure the additional reduction in
the error variance after all the other factors had been included. It
thus reﬂects the factor’s independent contribution toward ac-
counting for the variations in the dependent variable.
Results
We observed a wide variation in hospital readmission 30 days
after THA (interquartile range: 3.4%-9.1%, mean ± standard devia-
tion: 7.5% ± 9.6%, median: 5.8%), as well as 90 days after THA
(interquartile range: 7.3%-14.7%, mean ± standard deviation: 12.7% ±
12.2%, median: 10.5%). This interhospital variation was signiﬁcantly
based on their geography (Fig. 1). Patients in the western states had
the lowest readmission rates of 4.9% at 30 days and 8.5% at 90 days.
Other census regions had 30-day readmission rate at 6.0%-6.3% and
90-day rates at 10.2%-11.0%. Relative to the West, these rates were
10%-16% (30 days) and 7%-18% (90 days) higher, after adjusting for
other factors (P < .0001, Fig. 2). Besides geography, hospital proce-
dure volume (P < .0001) and nonproﬁt ownership (compared with
public hospital odds ratio: 1.10, P < .0001) were the only signiﬁcant
hospital factors among those we studied. Signiﬁcant effects associ-
ated with hospital volume and nonproﬁt ownership hospital factors
and 90-day readmission were also observed (Fig. 3). Hospital’s
teaching status, urban/rural location, and size of hospital had no
measurable association with readmission risk.
Overall, patients’ clinical factors had a much stronger associa-
tion with the risk of readmission than general hospital factors,
based on the relative values in the F statistics for each variable
(Figs. 2 and 3). Patients who required blood transfusion during the
primary surgery were associated with 14% greater risk (P < .0001);
each additional surgeon volume of 100 procedures had 7% reduc-
tion in risk (P < .0001); patients discharged to home had 28% less
risk than those discharged to another institution such as an SNF
(P < .0001); and LOS of 1-2 or 3-4 days was associated with 30%
reduction in risk of readmission, compared with patients requiring
5þ days of hospital stay (P < .0001). Based on the F statistics, these
effect sizes were at least comparable to other equally signiﬁcant but
ﬁxed patient factors, such as age, gender, comorbidities, and so-
cioeconomic status (Figs. 2 and 3).
The top 5 most frequently reported primary reasons for 30-day
readmission in THA were procedure related (Fig. 4): dislocation
(5.9%), deep infection (5.1%), wound infection (4.8%), periprosthetic
fracture (4.4%), or hematoma (3.4%). The top 5 reasons for 90-day
readmission were the same as those at 30 days (Fig. 5). The top 5
most commonly reported primary procedures during readmission
before 30 days were transfusion of packed cells (10.8%), revision of
femoral component (7.9%), closed reduction for dislocation of the
hip (4.8%), revision of acetabular and femoral components (4.4%),
and open reduction of fracture with internal ﬁxation (3.5%; Fig. 6).
The top 5 most commonly reported primary procedures during
readmission before 90 days were the same as those at 30 days
(Fig. 7).
Discussion
Hospital readmission after THA is a controversial topic because
of its implications for quality of care, hospital reimbursement, and
bundled payments. We studied the factors relating to 30- and
90-day readmissions after primary THA by analyzing the 100%
Medicare data set, which captures the outcomes for almost a half
Fig. 4. Principal diagnosis associated with 30-day readmission after total hip arthroplasty in the 100% Medicare data set (2010-2013).
Fig. 5. Principal diagnosis associated with 90-day readmission after total hip arthroplasty in the 100% Medicare data set (2010-2013).
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Fig. 6. Most commonly performed procedures during 30-day readmission after total hip arthroplasty in the 100% Medicare data set (2010-2013).
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gest that procedure-related factors and hospital factors have a role
in readmission risk. We also found that dislocation, periprosthetic
fracture, and infection were among the most frequently reported
reasons for readmission.
Our work is limited to administrative data, albeit the same data
used by used by CMS for establishing national quality measures and
benchmarks for THA [5]. The reasons for readmission were based
on ICD-9-CM diagnosis codes, which may be difﬁcult to unambig-
uously link to the quality of the index procedurewithout additional
clinical information. For example, without the details of why a
patient had a dislocation or a periprosthetic fracture, these com-
plications could reﬂect a problem with discharge disposition, as
they may not have been safe for home and fell at home, or the
rehabilitation facility was not attentive and they fell at that loca-
tion. Under such circumstances, a periprosthetic fracture would not
necessarily reﬂect on the quality of operative procedure, assuming
the operative X-rays indicated the device was properly placed
without malposition of the components. These ambiguities in
diagnosis precluded us from broadly categorizing reasons for
readmission at the present time. Our present ﬁndings are also
limited to the time frame between 2010 and 2013 and may be
inﬂuenced by changes in readmission rates over time, especially in
response to changes in reimbursement policy.
We are aware of one other study examining hospital factors and
30-day readmission after primary THA [9], limiting our ability to
make comparisons with the literature. Consistent with previous
research [9], we found that hospital procedure volume had an
inverse effect on 30- and 90-day readmissions. We also found that
nonproﬁt ownership was inversely related to readmission risk,which was not discussed in a previous study [9]. Surprisingly, the
geographic location of a hospital is an independent risk factor.
Hospitals located in thewestern states exhibited signiﬁcantly lower
readmission rates for THA compared with other regions of the
United States. The reasons underlying this geographic disparity
between hospitals remain unclear at this time.
Clinical factors that we found to be associated with the risk of
readmission include blood transfusion, LOS of 5 days, and
discharge to an SNF. Earlier work conducted at a single center also
identiﬁed these risk factors [8]. Previous studies have further
emphasized the patient-related factors such as comorbidities that
play a major role in readmission after surgery [6,8,9,15]. To reduce
risk of readmission, perhaps patients with increased potential for
postoperative transfusions could be identiﬁed during pretesting
andmanaged appropriately. For example, perioperative tranexamic
acid and different strategies for deep venous thrombosis prophy-
laxis are reported to result in reduced requirement for blood
transfusions [16,17]. A longer LOS may indicate a patient with a
more complicated course of recovery after primary THA [18].
However, if patients and families are made aware of the reduced
complication rate associated with a shorter LOS and home
discharge, they may be able to modify routines and allow family
members to convalesce at home. In addition to patient factors
during and after surgery, our analysis of presurgical medical
treatments showed that preoperative medical screening for heart
disease and renal failure was a strong indicator for increased
readmission at 30 and 90 days after surgery. If such ﬁndings are
conﬁrmed, it may be that there is a subset of patients whose pre-
surgical screening may show that they are too “high risk” to be part
of a bundled payment approach to THA.
Fig. 7. Most commonly performed procedures during 90-day readmission after total hip arthroplasty in the 100% Medicare data set (2010-2013).
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major reason for readmission.We showeddeep infection andwound
infection together accounted for 9.9% readmission at 30 days. At 90
days, the readmission rate for all causes of infectionwas 11.4%. These
are numbers of real concern. Further study is needed to determine
whetherhospital factors such aspresurgical screening and treatment
can ameliorate infection or whether increased risk of infection is
associatedwithpatient factors suchasdiabetes andobesityor indeed
with length of surgery and themore time-consuming technique that
may be required with “new” surgical procedures.
In summary, as hospital systems institute bundled payment
arrangements, the administration, the physicians, and the payers
involved will need to closely monitor the root causes of complica-
tions associated with THA and attempt to reduce the rate of 30- and
90-day readmissions. The facility and its physicians will be ﬁnan-
cially obligated to care for its readmitted patients, and establish-
ments with persistently high readmission rates may need to
reevaluate the future of their elective arthroplasty programs. We
expect that health care reformwill increasingly align the interests of
the hospital and surgeon to address the factors inﬂuencing read-
mission after THA. In light of the impressive variability we observed
among hospitals across the United States, the results of our study
suggest that there may be several different strategies for reducing
readmission by optimizing clinical pathways. Previous studies sug-
gest that readmissions are often attributable to patient factors and
medical-related causes unrelated to surgery [6,8,9,15]. Our analyses
of Medicare data further suggest that the top 5 reasons for 30 and
90-day readmissions may be related directly to the procedure itself.
These ﬁndings support further optimization of the delivery of carefor total hip arthroplasty, from the preoperative to intraoperative to
postoperative treatment plan, so that the morbidity and costs of
hospital readmissions may be reduced in the future.References
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